Net Loss Per Share (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2022

Dec. 31, 2021

Earnings Per Share [Abstract]

Summary of Basic and Diluted Net Income (Loss) Per Ordinary Share

The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2022 and 2021, respectively (in thousands, except share and per share data):

	Three Months Ended June 30,						Six Months Ended June 30,
	2022			2021			2022			2021
Numerator:
Net loss attributable to common stockholder, basic and diluted	$	(25,674	)	$	(20,467	)	$	(130,356	)	$	(35,181	)
Denominator:
Weighted average shares of common stock outstanding, basic and diluted		117,864,896			67,111,977			102,868,390			65,096,986
Net loss per share attributable to common stockholder, basic and diluted	$	(0.22	)	$	(0.30	)	$	(1.27	)	$	(0.54	)

	For the Years Ended December 31,
	2021			2020
Numerator:
Net loss attributable to common stockholder, basic and diluted	$	(63,544	)	$	(35,835	)
Denominator:
Weighted average shares of common stock outstanding, basic and diluted		64,938,930			57,247,816
Net loss per share attributable to common stockholder, basic and diluted	$	(0.98	)	$	(0.63	)

Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per share

The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would be anti-dilutive:

	As of June 30,
	2022		2021
Public warrants		13,799,988		—
Private placement warrants		7,520,000		—
GEM warrants		3,397,923		—
Stock options and RSUs issued and outstanding		12,427,763		10,168,130
Contingently returnable shares from GEM Agreement		2,677,192		—
Convertible notes		—		1,315,174
Potential common shares excluded from diluted net loss per share		39,822,866		11,483,304

The following table presents the potential common shares outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive:

	As of December 31,
	2021		2020
Stock options and RSUs issued and outstanding		15,257,453		10,167,927
Convertible notes		9,149,687		2,123,867
Potential common shares excluded from diluted net loss per share		24,407,140		12,291,794